(Q39649902)

13 September 2017

title

Prevalence of elevated serum prostate-specific antigen in rural Nigeria (English)

1 reference

13 September 2017

0 references

Rick Kittles

5

0 references

author name string

Flora Ukoli

1

1 reference

13 September 2017

Usifo Osime

2

1 reference

13 September 2017

Folasade Akereyeni

3

1 reference

13 September 2017

Osazuwa Okunzuwa

4

1 reference

13 September 2017

Lucile Adams-Campbell

6

1 reference

13 September 2017

publication date

1 June 2003

1 reference

International Journal of Urology

13 September 2017

published in

1 reference

13 September 2017

volume

10

1 reference

13 September 2017

issue

6

1 reference

13 September 2017

page(s)

315-322

1 reference

The epidemiology of prostate cancer in Jamaica

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2003.00633.X

Prostate cancer in Nigerians: facts and nonfacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2003.00633.X

The early detection of prostate carcinoma with prostate specific antigen: the Washington University experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2003.00633.X

Serum prostate-specific antigen and digital rectal examination for early detection of prostate cancer in a national community-based program. The Prostate Cancer Education Council

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2003.00633.X

Early detection of prostate cancer in Germany: a study using digital rectal examination and 4.0 ng/ml prostate-specific antigen as cutoff

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2003.00633.X

Benign prostatic hyperplasia and prostate carcinoma in native Africans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2003.00633.X

Comparative evaluation of total PSA, free/total PSA, and complexed PSA in prostate cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2003.00633.X

Longitudinal screening for prostate cancer with prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2003.00633.X

European randomized study of screening for prostate cancer--the Rotterdam pilot studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2003.00633.X

Free-to-total prostate-specific antigen (PSA) ratio improves the specificity for detecting prostate cancer in patients with prostatism and intermediate PSA levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2003.00633.X

10.1046/J.1442-2042.2003.00633.X

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference